Sun Pharma reports Q1FY19 results
The gross sales are at INR 7,139 crores up 16 per cent and adjusted net profit is at INR 983 crores up 87 per cent
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
The key focus for Boehringer Ingelheim India is diabetes, stroke, oncology and respiratory
Dr Michel Pairet, Member of the Board of Managing Directors, Innovation Unit, Boehringer Ingelheim, discloses about the company's…
DOP organises Indian Pharma Expo 2018
Indian Pharma Expo (IPE) 2018 held on August 7, 8 and 9, 2018 at Pragati Maidan, New Delhi
Playing for global stakes
Most bigger pharma companies have moved to the next level of exports: the trade of intellectual property, in the form of clinical…
For emerging technologies in pharma, choosing the right solution is always a challenge
As pharma companies in India strive to tap opportunities in large emerging markets, lean manufacturing techniques will play a…
Aptamers in cancer therapeutics
Dr Harleen Kaur,Senior Scientist, AstraZeneca USA, through her research paper, talks about collaborative approaches which can…
Pre-shipment inspection, testing and certification of pharmaceutical goods
Quntrol provides complete transparency and ensure integrity through their advanced proprietary digital software platform. Riddhi…
Genome editing using CRISPR-Cas9 system shows tremendous promise
Research published in Nature Medicine describes collaborative effort to reduce off-target CRISPR-Cas9 genome editing, removing…
ALEX provides guaranteed express delivery of pharma goods cost-effectively
Virendra Chaudhary, Director, Algor Logistics in a tête-à-tête with Express Pharma, speaks on the crucial role played by…
Eisai/Biogen to advance Alzheimer’s drug, provide fresh hope
According to Eisai, the company had already contacted various regulators and plans to pursue accelerated approvals